Ortho Clinical Diagnostics Holdings (OCDX)
NASDAQ:OCDX

Ortho Clinical Diagnostics Holdings Stock Analysis & Ratings

OCDX Stock Chart & Stats

Day’s Range$17.42 - $17.76
52-Week Range$16.04 - $22.99
Previous Close$17.64
Volume1.25M
Average Volume (3M)1.15M
Market Cap$4.15B
P/E Ratio-3565.3
Beta1.32
Next EarningsAug 03, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score2
EPS (TTM)0.00


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

OCDX FAQ

What was Ortho Clinical Diagnostics Holdings’s price range in the past 12 months?
Ortho Clinical Diagnostics Holdings lowest stock price was $16.04 and its highest was $22.99 in the past 12 months.
    What is Ortho Clinical Diagnostics Holdings’s market cap?
    Ortho Clinical Diagnostics Holdings’s market cap is $4.15B.
      What is Ortho Clinical Diagnostics Holdings’s price target?
      The average price target for Ortho Clinical Diagnostics Holdings is $21.44. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $24.68 ,the lowest forecast is $18.19. The average price target represents 22.72% Increase from the current price of $17.47.
        What do analysts say about Ortho Clinical Diagnostics Holdings?
        Ortho Clinical Diagnostics Holdings’s analyst rating consensus is a ‘Hold. This is based on the ratings of 2 Wall Streets Analysts.
          When is Ortho Clinical Diagnostics Holdings’s upcoming earnings report date?
          Ortho Clinical Diagnostics Holdings’s upcoming earnings report date is Aug 03, 2022 which is in 75 days.
            How were Ortho Clinical Diagnostics Holdings’s earnings last quarter?
            Ortho Clinical Diagnostics Holdings released its earnings results on May 04, 2022. The company reported $0.23 earnings per share for the quarter, beating the consensus estimate of $0.201 by $0.029.
              Is Ortho Clinical Diagnostics Holdings overvalued?
              According to Wall Street analysts Ortho Clinical Diagnostics Holdings’s price is currently Undervalued.
                Does Ortho Clinical Diagnostics Holdings pay dividends?
                Ortho Clinical Diagnostics Holdings does not currently pay dividends.
                What is Ortho Clinical Diagnostics Holdings’s EPS estimate?
                Ortho Clinical Diagnostics Holdings’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Ortho Clinical Diagnostics Holdings have?
                Ortho Clinical Diagnostics Holdings has 237,730,000 shares outstanding.
                  What happened to Ortho Clinical Diagnostics Holdings’s price movement after its last earnings report?
                  Ortho Clinical Diagnostics Holdings reported an EPS of $0.23 in its last earnings report, beating expectations of $0.201. Following the earnings report the stock price went down -1.109%.
                    Which hedge fund is a major shareholder of Ortho Clinical Diagnostics Holdings?
                    Among the largest hedge funds holding Ortho Clinical Diagnostics Holdings’s share is First Eagle Investment Management LLC. It holds Ortho Clinical Diagnostics Holdings’s shares valued at 2M.

                      ---

                      Ortho Clinical Diagnostics Holdings Stock Analysis

                      Smart Score
                      2
                      Underperform
                      1
                      2
                      3
                      4
                      5
                      6
                      7
                      8
                      9
                      10
                      Price Target
                      $21.44
                      ▲(22.72% Upside)
                      Hold
                      The Ortho Clinical Diagnostics Holdings stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description

                      Ortho Clinical Diagnostics Holdings

                      Ortho Clinical Diagnostics Holdings PLC offers in vitro diagnostics solutions and services. It provides diagnostic testing solutions to the clinical laboratory and transfusion medicine communities. The company operates through three geographic segments such as North America, EMEA, and Greater China. North America segment generates most of the revenue for firm.

                      ---
                      Popular Stocks

                      ---
                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis